Prognostic Biomarkers in Early-stage Gastric Adenocarcinoma Treated With Adjuvant Chemoradiotherapy

Conclusion: PTEN protein expression and KRAS mutations may predict disease outcome in early-stage gastric cancer. These results need to be further validated in larger cohorts.

Source: Cancer Genomics and Proteomics - April 27, 2020 Category: Cancer & Oncology Authors: PECTASIDES, E., CHATZIDAKIS, I., KOTOULA, V., KOLIOU, G.-A., PAPADOPOULOU, K., GIANNOULATOU, E., GIANNOUZAKOS, V. G., BOBOS, M., PAPAVASILEIOU, C., CHRISAFI, S., FLOROU, A., PECTASIDES, D., FOUNTZILAS, G. Tags: Article Source Type: research